Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.1610
-0.0080
(-4.73%)
As of 11:04:04 AM GMT+2. Market Open.
Loading Chart for 0NN.BE
- Previous Close
0.1690 - Open
0.1610 - Bid 0.1190 x --
- Ask 0.2000 x --
- Day's Range
0.1610 - 0.1610 - 52 Week Range
0.1180 - 0.3520 - Volume
0 - Avg. Volume
1,428 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 15, 2025 - Apr 29, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 0NN.BE
View MorePerformance Overview: 0NN.BE
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
0NN.BE
26.82%
S&P/TSX Composite index (^GSPTSE)
1.16%
1-Year Return
0NN.BE
45.97%
S&P/TSX Composite index (^GSPTSE)
10.36%
3-Year Return
0NN.BE
40.37%
S&P/TSX Composite index (^GSPTSE)
10.19%
5-Year Return
0NN.BE
70.46%
S&P/TSX Composite index (^GSPTSE)
88.09%
Compare To: 0NN.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.0556
-1.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0572
+0.70%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0574
-5.59%
Mkt Cap EUR 23.781M
Industry Drug Manufacturers—Specialty & Generic
0.1210
+9.01%
Mkt Cap EUR 34.786M
Industry Drug Manufacturers—Specialty & Generic
0.1452
0.00%
Mkt Cap 34.799M
Industry Drug Manufacturers—Specialty & Generic
0.2000
+8.11%
Mkt Cap CAD 49.478M
Industry Drug Manufacturers—Specialty & Generic
2.2000
0.00%
Mkt Cap CAD 6.788M
Industry Drug Manufacturers—Specialty & Generic
0.3800
-1.32%
Mkt Cap 21.462M
Industry Drug Manufacturers—Specialty & Generic
0.3500
+2.94%
Mkt Cap 71.597M
Industry Drug Manufacturers—Specialty & Generic
0.5300
+3.92%
Mkt Cap CAD 29.933M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 0NN.BE
View MoreValuation Measures
As of 4/3/2025
Market Cap
17.75M
Enterprise Value
17.38M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.00
Price/Book (mrq)
16.73
Enterprise Value/Revenue
1.08
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--